Benjamin is a business analyst for PharmaBoardroom, covering global healthcare and life sciences sectors. He holds a BA in Political Science from John Carroll University and an MSc in Development Management from the London School of Economics. He speaks English, Spanish and French.
Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on hospital investment. Throughout many of the healthcare systems in North America and Europe, there…
Despite the sharp decline in the Turkish lira’s value, the general mood among pharmaceutical executives in Turkey is positive. Rather than being discouraged, they are calling upon their resiliency and…
With the construction of state-of-the-art public and private hospitals, Turkey is poised to become a global leader in medical tourism. Turkey has always been a popular tourist destination, given…
In 2016 the Turkish Medicine and Medical Devices Agency (TiTCK) implemented a localisation policy to reduce Turkey’s reliance on imports – a few years later, it has created a young,…
See our Cookie Privacy Policy Here
